Establishment and Validation of a Gene Signature-Based Prognostic Model to Improve Survival Prediction in Adrenocortical Carcinoma Patients

BACKGROUND: The current guideline for the management of adrenocortical carcinoma (ACC) is insufficient for accurate risk prediction to guide adjuvant therapy. Given frequent and severe therapeutic side effects, a better estimate of survival is warranted for risk-specific assignment to adjuvant treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Xiaoqin, Liu, Zhenzhen, Jiao, Xuehua, Yin, Xueyan, Wang, Xiujie, Li, Gengxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632466/
https://www.ncbi.nlm.nih.gov/pubmed/34858497
http://dx.doi.org/10.1155/2021/2077633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632466/
https://www.ncbi.nlm.nih.gov/pubmed/34858497
http://dx.doi.org/10.1155/2021/2077633

Ejemplares similares